- Mononuclear copper(I) schiff base complex cu((Cl-NO2-ba)2en)I(CH3CN): Synthesis and crystal structure
-
New mononuclear copper(I) Schiff base complex Cu((Cl-NO2-ba)2en)I(CH3CN) (1) containing a bidentate Schiff base ligand (Cl-NO2-ba)2en = 2,4-dichloro-5-nitro-benzylidene-1,2-diaminopropane, was prepare
- Khalaji, Aliakbar Dehno,Dusek, Michal,Eigner, Vaclav,Peyghoun, Seyyed Javad
-
-
- Mononuclear copper(i) schiff base complex cu((Cl-NO2-ba)2en)i(CH3CN): Synthesis and crystal structure
-
New mononuclear copper(I) Schiff base complex Cu((Cl-NO2-ba)2en)I(CH3CN) (1) containing a bidentate Schiff base ligand (Cl-NO2-ba)2en = 2,4-dichloro-5-nitro-benzylidene-1,2- diaminopropane, was prepared in an acetonitrile
- Dusek, Michal,Eigner, Vaclav,Khalaji, Aliakbar Dehno,Peyghoun, Seyyed Javad
-
-
- Mononuclear Copper(I) Schiff Base Complex Cu((Cl-NO2-ba)2en)I(CH3CN): Synthesis and Crystal Structure
-
New mononuclear copper(I) Schiff base complex Cu((Cl-NO2-ba)2en)I(CH3CN) (1) containing a bidentate Schiff base ligand (Cl-NO2-ba)2en = 2,4-dichloro-5-nitro-benzylidene-1,2-diaminopropane, was prepared in an acetonitrile solution and characterized by elem
- Dusek, Michal,Eigner, Vaclav,Khalaji, Aliakbar Dehno,Peyghoun, Seyyed Javad
-
-
- Sulfonamide compounds and uses thereof as medicines
-
The present invention relates to a sulfonamide compound of the formula (I): wherein each symbol is as defined in the specification, a salt thereof, and a pharmaceutical composition containing same. This compound can be an effective agent for the prophylaxis and treatment of the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle cell inhibitory action and an allergy suppressing action.
- -
-
-
- Substituted aromatic phoshonic acid derivatives
-
Phosphonic acid compounds I wherein Eth is optionally substituted 1,2-ethynediyl, ethanediyl or ethene-1,2-diyl; Y1is oxygen or sulfur; Y2is oxygen, sulfur or —N(R6)—; Y3is oxygen, sulfur or —N(R7)—; R1, R2, R6and R7are hydrogen or optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, phenyl or heterocyclyl, or R1and R2, R1and R6, R2and R7together are optionally substituted 1,2-ethanediyl, 1,3-propylene, tetramethylene, pentamethylene or ethyleneoxyethylene, or R1and R2together are optionally substituted 1,2-phenylene; R3is cyano, halogen, alkyl, haloalkyl, alkoxy or haloalkoxy; R4is hydrogen or halogen, and R5is a heterocycle Φ1to Φ22as defined in the specification, their manufacture and intermediates therefore. The phosphonic acid compounds are effective against unwanted plants and act as desiccants and defoliants.
- -
-
-
- Process for the production of nitro derivatives of aromatic compounds
-
Nitroderivates of aromatic compounds which are difficult to nitrate, can readily be obtained by nitration providing that the aromatic compound is treated with nitric acid or another nitrating agent in the presence of aliphatic or cycloaliphatic hydrocarbons monosubstituted or polysubstituted by halogen, the nitro group or an alkyl sulphonyl group, and the nitro derivative formed subsequently isolated.
- -
-
-